Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Explore the primary drivers of risk in Dividend Aristocrats ETF, including sector shifts and interest-rate impacts, with practical mitigation tips.
26,217 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
At New Delhi's AI Impact Summit, a staged gesture exposed rivalries among top AI leaders, triggering a rethink of AI ...
A new wave of AI infrastructure spending from Meta Platforms is shaping the outlook for Nvidia and the cloud ecosyste...
Even with a $3 million nest egg, retiring at 50 is not automatic. A rising cost of care, taxes, and the chance of mar...
A parent who vanished from a child’s life decades ago resurfaces in their 50s asking for money, forcing a choice that...
The U.S. Treasury proposes a drastic sanction to cut a Swiss bank off from dollar clearing amid suspected Iran and Ru...
Public headlines rarely tell the whole story about the economy or your wallet. This article breaks down how political...
Industry discussions on a nationwide MLS are back in 2026 as experts weigh federation models to unify data and govern...
Bitcoin climbs above $71,000, fueling a premarket lift in crypto-linked stocks. Coinbase and Circle lead gains as inv...
Ambiq Micro shares jumped as investors priced in stronger demand for ultra-low-power edge AI technology. This article...
Ethereum co-founder Vitalik Buterin floated a model where AI assists with wallet decisions but humans approve large t...
Tempted to place a quick AI bet? This guide shows why buying Alphabet (GOOG/GOOGL) stock may offer more durable gains...